A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Ex Situ Normothermic Machine Perfusion of Donor Livers

11.5K views

DOI:

10.3791/52688

May 26th, 2015

In This Article

Summary

Here we present a protocol describing oxygenated ex situ machine perfusion of donor liver grafts. This article contains a step by step protocol to procure and prepare the liver graft for machine perfusion, prepare the perfusion fluid, prime the perfusion machine and perform oxygenated normothermic machine perfusion of the liver graft.

Abstract

In contrast to conventional static cold preservation (0-4 °C), ex situ machine perfusion may provide better preservation of donor livers. Continuous perfusion of organs provides the opportunity to improve organ quality and allows ex situ viability assessment of donor livers prior to transplantation. This video article provides a step by step protocol for ex situ normothermic machine perfusion (37 °C) of human donor livers using a device that provides a pressure and temperature controlled pulsatile perfusion of the hepatic artery and continuous perfusion of the portal vein. The perfusion fluid is oxygenated by two hollow fiber membrane oxygenators and the temperature can be regulated between 10 °C and 37 °C. During perfusion, the metabolic activity of the liver as well as the degree of injury can be assessed by biochemical analysis of samples taken from the perfusion fluid. Machine perfusion is a very promising tool to increase the number of livers that are suitable for transplantation.

Introduction

The current method of organ preservation in liver transplantation is flush out with and subsequent storage of donor livers in cold (0-4 °C) preservation fluid (such as University of Wisconsin solution or Histidine-Tryptophan-Ketoglutarate solution). This method is referred to as static cold storage (SCS). Although the metabolic rate of livers at 0-4 °C is very low, there is still demand for 0.27 µmol oxygen/min/g liver tissue, which cannot be provided during SCS1. The conventional method of SCS, therefore, results in some degree of (additional) injury of donor livers. While this amount of preservation injury is not a problem in donor livers of good quality,....

Access restricted. Please log in or start a trial to view this content.

Protocol

This protocol has been approved by the Medical Ethical Committee (Medisch Ethische Toetsingscommissie) of the University Medical Center Groningen, the Netherlands.

1. Preparation of the Perfusion Fluid

Note: The total volume of the perfusion fluid prepared for normothermic machine perfusion according to this protocol is 2,233 ml and the targeted osmolarity of the perfusion fluid is 302 mOsmol/L.

  1. From the components of the perfusion fluid described in Table 1, keep the human packed red blood cells, fresh frozen plasma and human albumin separated. Mix the rest of the components in a ste....

Access restricted. Please log in or start a trial to view this content.

Results

12 human livers that were declined for transplantation due to various reasons were used after obtaining informed consent for research from donor families. Donor characteristics are described in Table 2. The human donor livers were perfused normothermically for 6 hr by using the protocol described in this paper. The quality of the liver grafts were evaluated by monitoring the macroscopic homogeneity of liver perfusion (Figure 2A-D). The hemodynamics of th.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This video provides a step by step protocol for normothermic machine perfusion of human donor livers using a device that enables pressure controlled dual perfusion through the hepatic artery and portal vein. While following this protocol, technical failures of the perfusion machine did not occur and all grafts were well perfused and well oxygenated. The ex situ perfused livers had stable hemodynamics and were metabolically active, as defined by the production of bile16,17.

.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors of this manuscript have no conflict of interest to disclose.

Acknowledgements

This research work was financially supported by grants provided by Innovatief Actieprogramma Groningen (IAG-3), Jan Kornelis de Cock Stichting and Tekke Huizingafonds, all in the Netherlands. We are appreciative to all the Dutch transplantation coordinators for identifying the potential discarded livers and obtaining informed consent.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Liver AssistOrgan AssistOA.Li.Li.140Perfusion device
Liver Assist disposable packageOrgan AssistOA.Li.DP.540Disposable set and cannulas
Meredith No.8Vygon Nederlands B.V.1362082Bile duct cannula
Human albumin 200 g/L / ALBUMANSanquin15522598100 ml
Modified parenteral nutritionBaxter Nederland B.V.N14G30E7.35 ml
Multivitamins for infusion / CERNEVITBaxter International Inc.98009277 μl
Concentrated trace elements for infusion / NUTRITRACEB. Braun Melsungen AG148113327.35 ml
Metronidazole 5 mg/mlBaxter Nederland B.V.9818188240 ml
Cefazoline / SERVAZOLINSandoz B.V.156113372 ml
Fast acting insulinvarious vendors20 ml
Calcium glubionate, intravenous solution 10%, 137.5 mg/mlSandoz9703869540 ml
Sterile H2OFresenius Kabi Nederland B.V.9808445351.3 ml
NaCl 0.9%Baxter Nederland B.V.15262510160 ml
Heparin 5,000 IE/ml for i.v. administrationLEO Pharma B.V.980261784 ml
Sodium bicarbonate 8.4%B. Braun Melsungen AG97973874The amount depends on the pH
Packed red blood cell (in SAGM)Blood bank (Sanquin)N0012000750 ml
Fresh frozen plasmaBlood bank (Sanquin)N04030A0/N04030B0900 ml

References

  1. Plaats, A., et al. Hypothermic machine preservation in liver transplantation revisited: Concepts and criteria in the new millennium. Ann. Biomed. Eng. 32 (4), 623-631 (2004).
  2. op den Dries, S., Sutton, M. E., Lisman, Y., Porte, R. J.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Ex Situ PerfusionDonor Liver PerfusionHepatic Artery PerfusionPortal Vein PerfusionBlood Gas AnalysisPerfusion Fluid PreparationOrgan Chamber SetupCannulation ProcedureViability Assessment